This announcement is a separate document:
诚达药业：关于达格列净原料药通过CDE审批的公告
Chengda Pharmaceutical: Announcement on the CDE approval of the active ingredient dagliflozin
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated